Hsieh HY - Search Results

1

Association between survivin gene promoter -31 C/G polymorphism and urothelial carcinoma risk in Taiwanese population.

Wang YH, Chiou HY, Lin CT, Hsieh HY, Wu CC, Hsu CD, Shen CH. Wang YH, et al. Among authors: hsieh hy. Urology. 2009 Mar;73(3):670-4. doi: 10.1016/j.urology.2008.09.048. Epub 2008 Nov 26. Urology. 2009. PMID: 19038421

2

Inducible nitric oxide synthase promoter polymorphism, cigarette smoking, and urothelial carcinoma risk.

Shen CH, Wang YH, Wang WC, Jou YC, Hsu HS, Hsieh HY, Chiou HY. Shen CH, et al. Among authors: hsieh hy. Urology. 2007 May;69(5):1001-6. doi: 10.1016/j.urology.2007.02.028. Urology. 2007. PMID: 17482959

3

High Dickkopf-1 expression is associated with poor prognosis in patients with advanced urothelial carcinoma.

Shen CH, Hsieh HY, Wang YH, Chen SY, Tung CL, Wu JD, Lin CT, Chan MW, Hsu CD, Chang D. Shen CH, et al. Among authors: hsieh hy. Exp Ther Med. 2010 Sep;1(5):893-898. doi: 10.3892/etm.2010.134. Epub 2010 Jul 21. Exp Ther Med. 2010. PMID: 22993615 Free PMC article.

4

The investigation of a traditional Chinese medicine, Guizhi Fuling Wan (GFW) as an intravesical therapeutic agent for urothelial carcinoma of the bladder.

Lu CC, Lin MY, Chen SY, Shen CH, Chen LG, Hsieh HY, Chan MW, Hsu CD. Lu CC, et al. Among authors: hsieh hy. BMC Complement Altern Med. 2013 Feb 23;13:44. doi: 10.1186/1472-6882-13-44. BMC Complement Altern Med. 2013. PMID: 23433042 Free PMC article.

5

Age-dependent association between Dickkopf-1 and calcium-containing urolithiasis.

Jou YC, Tsai YS, Hsieh HY, Shen CH, Fang CY, Chen SY, Lin MF, Chen FH, Hsu CD. Jou YC, et al. Among authors: hsieh hy. Urology. 2014 May;83(5):1006-10. doi: 10.1016/j.urology.2013.12.017. Epub 2014 Feb 12. Urology. 2014. PMID: 24529587

6

Clinical significance of survivin expression in patients with urothelial carcinoma.

Chen HA, Su CM, Hsieh HY, Tung CL, Hsu CD, Wang YH, Shen CH. Chen HA, et al. Among authors: hsieh hy. Dis Markers. 2014;2014:574985. doi: 10.1155/2014/574985. Epub 2014 Feb 5. Dis Markers. 2014. PMID: 24648609 Free PMC article.

7

Sequence variants of the HTR3A gene contribute to the genetic prediction of postoperative nausea in Taiwan.

Joy Lin YM, Hsu CD, Hsieh HY, Tseng CC, Sun HS. Joy Lin YM, et al. Among authors: hsieh hy. J Hum Genet. 2014 Dec;59(12):655-60. doi: 10.1038/jhg.2014.89. Epub 2014 Oct 23. J Hum Genet. 2014. PMID: 25339231

8

Cyproheptadine, an antihistaminic drug, inhibits proliferation of hepatocellular carcinoma cells by blocking cell cycle progression through the activation of P38 MAP kinase.

Feng YM, Feng CW, Chen SY, Hsieh HY, Chen YH, Hsu CD. Feng YM, et al. Among authors: hsieh hy. BMC Cancer. 2015 Mar 17;15:134. doi: 10.1186/s12885-015-1137-9. BMC Cancer. 2015. PMID: 25886177 Free PMC article.

9

Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential non-invasive biomarker for the detection of urothelial carcinoma.

Yeh CM, Chen PC, Hsieh HY, Jou YC, Lin CT, Tsai MH, Huang WY, Wang YT, Lin RI, Chen SS, Tung CL, Wu SF, Chang DC, Shen CH, Hsu CD, Chan MW. Yeh CM, et al. Among authors: hsieh hy. Oncotarget. 2015 Oct 6;6(30):29555-72. doi: 10.18632/oncotarget.4986. Oncotarget. 2015. PMID: 26320192 Free PMC article.

10

Cyproheptadine exhibits antitumor activity in urothelial carcinoma cells by targeting GSK3β to suppress mTOR and β-catenin signaling pathways.

Hsieh HY, Shen CH, Lin RI, Feng YM, Huang SY, Wang YH, Wu SF, Hsu CD, Chan MW. Hsieh HY, et al. Cancer Lett. 2016 Jan 1;370(1):56-65. doi: 10.1016/j.canlet.2015.09.018. Epub 2015 Oct 21. Cancer Lett. 2016. PMID: 26454215

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

318 results

Search Page

Filters